Sun, Jun 22, 2025
[Archive]
Volume 26, Issue 116 (7-2018)
J Adv Med Biomed Res 2018, 26(116): 88-99 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khodadadi I, Ghasemkhani N, Shafiee G R. Inhibition of Gastric Cancer Cell Growth and Proliferation by Genistein. J Adv Med Biomed Res 2018; 26 (116) :88-99
URL: http://journal.zums.ac.ir/article-1-5089-en.html
URL: http://journal.zums.ac.ir/article-1-5089-en.html
1- Dept. of Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan-Iran , khodadadi@umsha.ac.ir
2- Dept. of Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan-Iran
2- Dept. of Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan-Iran
Abstract: (167104 Views)
Background and Objective: Compelling evidence exists in favor of the effectiveness of herbal plant-derived components in cancer treatment; however their exact mechanisms of action are not well understood. Since the alteration of mitogen-activated protein kinase enzymes (MAPKs) has been reported in different cancer types, the present study aimed to investigate the effects of soy isoflavonoid genistein on the inhibition of cell viability and proliferation of AGS gastric cancer cell line by determining p38MAPK gene expression and also protein levels.
Materials and Methods: Cell viability was determined by MTT assay at different genistein concentrations (0, 50, 70, and 90 µM) after 24 hours of incubation. Quantitative Real-time PCR was carried out to obtain p38MAPK gene expression levels and its active phosphorylated protein (p-p38MAPK) was measured by flow cytometry.
Results: Genistein significantly reduced cell viability in a concentration and time-dependent manner. Exposure of gastric cancer cells to 0, 50, 70, and 90 µM genistein down-regulated p38MAPK gene expression by 83, 56, and 57%, and reduced cell proliferation by 35, 52, and 67%, respectively. In addition, a great reduction was observed in p-p38MAPK protein levels in treated cells compared to untreated control cells.
Conclusion: Since different concentrations of genistein reduced p38MAPK gene expression and lowered proliferation of AGS gastric cancer cells, it might be a potent candidate for a therapeutic plant-derived agent for combination therapy in gastric cancer.
Keywords: Apoptosis, Gastric neoplasms, Gene expression, Genistein, p38 mitogen-activated protein kinase, Proliferation
Type of Study: Clinical Trials |
Received: 2018/03/3 | Accepted: 2018/03/3 | Published: 2018/03/3
Received: 2018/03/3 | Accepted: 2018/03/3 | Published: 2018/03/3
References
1. Hernandez LJ, Parada CC, Guinea VJ, et al. Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene. 2003; 22: 3998-4006. [DOI:10.1038/sj.onc.1206608] [PMID]
2. Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011; 396: 729-42. [DOI:10.1007/s00423-011-0810-y] [PMID]
3. Emadi-Baygi M, Nikpour P, Mohammad-Hashem F, et al. MSI2 expression is decreased in grade II of gastric carcinoma. Pathol Res Pract. 2013; 209: 689-91. [DOI:10.1016/j.prp.2013.07.008] [PMID]
4. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001; 81: 807-69. [DOI:10.1152/physrev.2001.81.2.807] [PMID]
5. Glatz G, Gogl G, Alexa A, et al. Structural mechanism for the specific assembly and activation of the extracellular signal regulated kinase 5 (ERK5) module. J Biol Chem. 2013; 288: 8596-8609. [DOI:10.1074/jbc.M113.452235] [PMID] [PMCID]
6. Burotto M, Chiou VL, Lee JM, et al. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014; 120: 3446-56. [DOI:10.1002/cncr.28864] [PMID] [PMCID]
7. Koul HK, Pal M, Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer. 2013; 4: 342-59. [DOI:10.1177/1947601913507951] [PMID] [PMCID]
8. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009; 9: 537-49. [DOI:10.1038/nrc2694] [PMID]
9. Thornton TM, Pedraza-Alva G, Deng B, et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science. 2008; 320: 667-70. [DOI:10.1126/science.1156037] [PMID] [PMCID]
10. Florou D, Patsis C, Ardavanis A, et al. Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells. Cancer Biol Ther. 2013; 14: 587-96. [DOI:10.4161/cbt.24591] [PMID] [PMCID]
11. Kim JG. Molecular targeted therapy for advanced gastric cancer. Korean J Intern Med. 2013; 28: 149-55. [DOI:10.3904/kjim.2013.28.2.149] [PMID] [PMCID]
12. Merchant K, Kumi-Diaka J, Rathinavelu A, et al. Genistein modulation of immune-associated genes in LNCaP prostate cancer cell line. The Open Prostate Cancer J. 2012; 5: 1-7. [DOI:10.2174/1876822901205010001]
13. Li Y, Kong D, Bao B, et al. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients. 2011; 3: 877-96. [DOI:10.3390/nu3100877] [PMID] [PMCID]
14. Cui HB, Na XL, Song DF, et al. Blocking effects of genistein on cell proliferation and possible mechanism in human gastric carcinoma. World J Gastroenterol. 2005; 11: 69-72. [DOI:10.3748/wjg.v11.i1.69] [PMID] [PMCID]
15. Choi EJ, Jung JY, Kim GH. Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERalpha expression and induction of apoptosis. Exp Ther Med. 2014; 8: 454-58. [DOI:10.3892/etm.2014.1771] [PMID] [PMCID]
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8. [DOI:10.1006/meth.2001.1262] [PMID]
17. Shafiee G, Saidijam M, Tavilani H, et al. Genistein induces apoptosis and inhibits proliferation of HT29 colon cancer cells. Int J Mol Cell Med. 2016; 5: 178-91.
18. Touny LH, Banerjee PP. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate. 2006; 66: 1542-55. [DOI:10.1002/pros.20495] [PMID]
19. Shen J, Tai YC, Zhou J, et al. Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling. Exp Hematol. 2007; 35: 75-83. [DOI:10.1016/j.exphem.2006.09.007] [PMID]
20. Jin CY, Park C, Kim GY, et al. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem Biol Interact. 2009; 180: 143-50. [DOI:10.1016/j.cbi.2009.03.020] [PMID]
21. Wang X, Clubbs EA, Bomser JA. Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem. 2006; 17: 204-10. [DOI:10.1016/j.jnutbio.2005.07.005] [PMID]
22. Tan W, Yu HG, Luo HS. Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo. Mol Med Rep. 2014; 10: 3275-81. [DOI:10.3892/mmr.2014.2598] [PMID]
23. Amado NG, Fonseca BF, Cerqueira DM, et al. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 2011; 89: 545-54. [DOI:10.1016/j.lfs.2011.05.003] [PMID]
24. Wang Z, Zhang Y, Banerjee S, et al. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer. 2006; 118: 1930-36. [DOI:10.1002/ijc.21589] [PMID]
25. Sui X, Kong N, Ye L, et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 2014; 344: 174-79. [DOI:10.1016/j.canlet.2013.11.019] [PMID]
26. Cui Q, Tashiro S, Onodera S, et al. Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation. J Pharmacol Sci. 2007; 105: 317-25. [DOI:10.1254/jphs.FP0070336]
27. Zhou C, Zhou J, Sheng F, et al. The heme oxygenase-1 inhibitor ZnPPIX induces non-canonical, Beclin 1-independent, autophagy through p38 MAPK pathway. Acta Biochim Biophys Sin (Shanghai). 2012; 44: 815-22. [DOI:10.1093/abbs/gms064] [PMID]
28. Igea A, Nebreda AR. The stress kinase p38 as a target for cancer therapy. Cancer research. 2015; 75: 3997-4002. [DOI:10.1158/0008-5472.CAN-15-0173] [PMID]
29. Grossi V, Peserico A, Tezil T, et al. p38alpha MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol. 2014; 20: 9744-58. [DOI:10.3748/wjg.v20.i29.9744] [PMID] [PMCID]
30. Guo X, Ma N, Wang J, et al. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer. 2008; 8: 375. [DOI:10.1186/1471-2407-8-375] [PMID] [PMCID]
31. del Barco Barrantes I, Nebreda AR. Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans. 2012; 40: 79-84. [DOI:10.1042/BST20110676] [PMID]
32. Huang HL, Hsieh MJ, Chien MH, et al. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One. 2014; 9: e98943. [DOI:10.1371/journal.pone.0098943] [PMID] [PMCID]
33. Zhang X, Zhu Y, Duan W, et al. Allicin induces apoptosis of the MGC-803 human gastric carcinoma cell line through the p38 mitogen-activated protein kinase/caspase-3 signaling pathway. Mol Med Rep. 2015; 11: 2755-60. [DOI:10.3892/mmr.2014.3109] [PMID]
34. Yang M, Huang CZ. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol. 2015; 21: 11673-79. [DOI:10.3748/wjg.v21.i41.11673] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
